ALN-SNCA clinical trials

First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)

This study is testing a new drug for early Parkinson's disease called ALN-SNCA. Researchers want to see if it's safe, how the body handles it, and if it can lower a protein linked to Parkinson's. It's a first step to see if this treatment might help slow the disease.